IL97148A - Oxtanones, the process for their preparation and the pharmaceutical preparations containing them - Google Patents
Oxtanones, the process for their preparation and the pharmaceutical preparations containing themInfo
- Publication number
- IL97148A IL97148A IL9714891A IL9714891A IL97148A IL 97148 A IL97148 A IL 97148A IL 9714891 A IL9714891 A IL 9714891A IL 9714891 A IL9714891 A IL 9714891A IL 97148 A IL97148 A IL 97148A
- Authority
- IL
- Israel
- Prior art keywords
- methyl
- oxo
- oxetanyl
- group
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
- C07D305/12—Beta-lactones
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epoxy Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polyesters Or Polycarbonates (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH60490 | 1990-02-26 | ||
CH400590 | 1990-12-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL97148A0 IL97148A0 (en) | 1992-05-25 |
IL97148A true IL97148A (en) | 1996-11-14 |
Family
ID=25685091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9714891A IL97148A (en) | 1990-02-26 | 1991-02-05 | Oxtanones, the process for their preparation and the pharmaceutical preparations containing them |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0444482B1 (da) |
JP (1) | JP2753403B2 (da) |
KR (1) | KR0183036B1 (da) |
AT (1) | ATE133167T1 (da) |
AU (1) | AU645291B2 (da) |
CA (1) | CA2035967C (da) |
DE (1) | DE59107262D1 (da) |
DK (1) | DK0444482T3 (da) |
ES (1) | ES2082869T3 (da) |
FI (1) | FI115054B (da) |
GR (1) | GR3019618T3 (da) |
HU (1) | HU218272B (da) |
IE (1) | IE72196B1 (da) |
IL (1) | IL97148A (da) |
MC (1) | MC2226A1 (da) |
NO (1) | NO177055C (da) |
NZ (1) | NZ237170A (da) |
PT (1) | PT96887B (da) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2035972C (en) * | 1990-02-23 | 2006-07-11 | Martin Karpf | Process for the preparation of oxetanones |
CA2098167C (en) * | 1992-06-24 | 2006-12-19 | Dorothea Isler | Foodstuffs and feedstuffs containing a lipase inhibitor |
NL1004559C2 (nl) * | 1996-11-18 | 1998-05-19 | Unilife | Boter. |
AU1238101A (en) * | 1999-10-29 | 2001-05-14 | John Jason Gentry Mullins | Oxetanone derivatives |
US6348492B1 (en) * | 1999-10-29 | 2002-02-19 | 2Pro Chemical | Oxetanone derivatives |
US6342519B2 (en) * | 1999-10-29 | 2002-01-29 | 2 Pro Chemical | Oxetanone derivatives |
DE102004009076A1 (de) * | 2004-02-23 | 2005-10-27 | Solvay Pharmaceuticals Gmbh | Alkylcarbamat-substituierte β-Lactone, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
US7074822B2 (en) | 2004-02-23 | 2006-07-11 | Solvay Pharmaceuticals Gmbh | Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them |
CA2704462A1 (en) | 2007-10-31 | 2009-05-07 | Burnham Institute For Medical Research | Beta-lactone compounds |
AU2018300985A1 (en) * | 2017-07-12 | 2020-01-30 | Mayo Foundation For Medical Education And Research | Compounds for the reducing lipotoxic damage |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS608117B2 (ja) * | 1977-02-08 | 1985-02-28 | 財団法人微生物化学研究会 | 新生理活性物質エステラスチンおよびその製造法 |
GB2023604B (en) * | 1978-05-25 | 1982-07-28 | Microbial Chem Res Found | Physiologically active derivatives of esterastin and production thereof |
JPH0669130B2 (ja) * | 1984-08-09 | 1994-08-31 | 三菱電機株式会社 | 遅延線 |
-
1991
- 1991-02-05 IL IL9714891A patent/IL97148A/en active IP Right Grant
- 1991-02-07 CA CA002035967A patent/CA2035967C/en not_active Expired - Fee Related
- 1991-02-15 DE DE59107262T patent/DE59107262D1/de not_active Expired - Fee Related
- 1991-02-15 DK DK91102151.7T patent/DK0444482T3/da not_active Application Discontinuation
- 1991-02-15 ES ES91102151T patent/ES2082869T3/es not_active Expired - Lifetime
- 1991-02-15 EP EP91102151A patent/EP0444482B1/de not_active Expired - Lifetime
- 1991-02-15 AT AT91102151T patent/ATE133167T1/de not_active IP Right Cessation
- 1991-02-20 NZ NZ237170A patent/NZ237170A/en unknown
- 1991-02-20 AU AU71228/91A patent/AU645291B2/en not_active Ceased
- 1991-02-20 HU HU61/91A patent/HU218272B/hu not_active IP Right Cessation
- 1991-02-21 MC MC912172A patent/MC2226A1/xx unknown
- 1991-02-22 JP JP3131730A patent/JP2753403B2/ja not_active Expired - Fee Related
- 1991-02-25 NO NO910729A patent/NO177055C/no unknown
- 1991-02-25 IE IE63191A patent/IE72196B1/en not_active IP Right Cessation
- 1991-02-26 FI FI910925A patent/FI115054B/fi not_active IP Right Cessation
- 1991-02-26 PT PT96887A patent/PT96887B/pt not_active IP Right Cessation
- 1991-02-26 KR KR1019910003075A patent/KR0183036B1/ko not_active IP Right Cessation
-
1996
- 1996-04-09 GR GR960401013T patent/GR3019618T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO910729D0 (no) | 1991-02-25 |
EP0444482B1 (de) | 1996-01-17 |
ES2082869T3 (es) | 1996-04-01 |
CA2035967C (en) | 2001-10-16 |
MC2226A1 (fr) | 1993-02-02 |
FI115054B (fi) | 2005-02-28 |
FI910925A0 (fi) | 1991-02-26 |
DK0444482T3 (da) | 1996-05-06 |
KR0183036B1 (ko) | 1999-05-01 |
PT96887A (pt) | 1991-10-31 |
FI910925A (fi) | 1991-08-27 |
HU218272B (en) | 2000-07-28 |
AU645291B2 (en) | 1994-01-13 |
IL97148A0 (en) | 1992-05-25 |
CA2035967A1 (en) | 1991-08-27 |
JP2753403B2 (ja) | 1998-05-20 |
IE72196B1 (en) | 1997-03-26 |
ATE133167T1 (de) | 1996-02-15 |
AU7122891A (en) | 1991-08-29 |
JPH0770099A (ja) | 1995-03-14 |
GR3019618T3 (en) | 1996-07-31 |
PT96887B (pt) | 1998-09-30 |
DE59107262D1 (de) | 1996-02-29 |
NO910729L (no) | 1991-08-27 |
NO177055B (no) | 1995-04-03 |
NZ237170A (en) | 1993-12-23 |
KR910021391A (ko) | 1991-12-20 |
EP0444482A2 (de) | 1991-09-04 |
NO177055C (no) | 1995-07-12 |
IE910631A1 (en) | 1991-08-28 |
EP0444482A3 (en) | 1991-12-04 |
HUT56557A (en) | 1991-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5260310A (en) | Oxetanone compounds and pharmaceutical compositions containing them | |
EP0525420B1 (en) | Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors | |
US5618844A (en) | Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof | |
DE69432614T2 (de) | Alkohol und Aldehyde Derivate als Cathepsin L Inhibitore und als Inhibitore der Knochenresorption | |
DE3881489T2 (de) | Peptide mit collagenase hemmender wirkung. | |
DE2925945C2 (da) | ||
IL97148A (en) | Oxtanones, the process for their preparation and the pharmaceutical preparations containing them | |
HUT74511A (en) | Metalloproteinase inhibitors, pharmaceutical compns. contg. them and process to prepare the said compds. | |
HRP980096A2 (en) | Reverse hydroxamate derivatives as matrix metalloprotease inhibitors, metalloprotease inhibitors, and tnf alpha inhibitors | |
EP0810221A1 (en) | Oxygen-containing heterocyclic derivatives | |
US6444849B1 (en) | Amide derivatives | |
BE1003848A3 (fr) | Nouveaux derives de la thiouree, leur preparation et leur utilisation comme medicaments. | |
HUT57705A (en) | Process for producing acat-inhibitors | |
EP0520427B1 (en) | Cyclopropenone derivatives | |
US4594443A (en) | Derivatives of 4-phenyl-4-oxo-buten-2-oic acid and therapeutic use thereof | |
EP0848957A1 (en) | Fas LIGAND SOLUBILIZATION INHIBITOR | |
JPH06102639B2 (ja) | アミノ酸誘導体 | |
US5506259A (en) | β-mercapto-propanamide derivatives useful in the treatment of cardiovascular diseases | |
US5438046A (en) | N-heteroaryl substituted derivatives of propanamide useful in the treatment of cardiovascular diseases | |
EP0925786A1 (en) | Remedies for ischemic diseases | |
JPS61152663A (ja) | オキセタノン類 | |
KR20010020452A (ko) | 금속 단백질 분해효소 억제제 | |
JPH09188631A (ja) | Fasリガンド可溶化抑制薬 | |
SA91110250B1 (ar) | اوكستانونات oxetanones | |
JP2000086611A (ja) | 新規なメタロプロテイナ―ゼ阻害剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed |